Logo of jphysiolThe Journal of Physiology SiteMembershipSubmissionJ Physiol
J Physiol. Apr 15, 2008; 586(Pt 8): 2231–2244.
Published online Feb 28, 2008. doi:  10.1113/jphysiol.2007.149229
PMCID: PMC2465188

Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring


Early embryonic development is known to be susceptible to maternal undernutrition, leading to a disease-related postnatal phenotype. To determine whether this sensitivity extended into oocyte development, we examined the effect of maternal normal protein diet (18% casein; NPD) or isocaloric low protein diet (9% casein; LPD) restricted to one ovulatory cycle (3.5 days) prior to natural mating in female MF-1 mice. After mating, all females received NPD for the remainder of gestation and all offspring were litter size adjusted and fed standard chow. No difference in gestation length, litter size, sex ratio or postnatal growth was observed between treatments. Maternal LPD did, however, induce abnormal anxiety-related behaviour in open field activities in male and female offspring (P < 0.05). Maternal LPD offspring also exhibited elevated systolic blood pressure (SBP) in males at 9 and 15 weeks and in both sexes at 21 weeks (P < 0.05). Male LPD offspring hypertension was accompanied by attenuated arterial responsiveness in vitro to vasodilators acetylcholine and isoprenaline (P < 0.05). LPD female offspring adult kidneys were also smaller, but had increased nephron numbers (P < 0.05). Moreover, the relationship between SBP and kidney or heart size or nephron number was altered by diet treatment (P < 0.05). These data demonstrate the sensitivity of mouse maturing oocytes in vivo to maternal protein undernutrition and identify both behavioural and cardiovascular postnatal outcomes, indicative of adult disease. These outcomes probably derive from a direct effect of protein restriction, although indirect stress mechanisms may also be contributory. Similar and distinct postnatal outcomes were observed here compared with maternal LPD treatment during post-fertilization preimplantation development which may reflect the relative contribution of the paternal genome.

Recent studies have shown preimplantation mammalian development to be sensitive to both in vivo and in vitro environmental conditions resulting in altered blastocyst potential and long-term changes in fetal and postnatal health and physiology (Thompson et al. 1995; Sinclair et al. 1999, 2007; Kwong et al. 2000; Ecker et al. 2004; Fernandez-Gonzalez et al. 2004; Fleming et al. 2004; Sinclair & Singh, 2007; Watkins et al. 2007, 2008). This sensitivity in vivo may be explained by the ‘Developmental Origins of Health and Disease’ (DOHaD) hypothesis which proposes that changes in the uterine environment mediated by maternal dietary quality induce responses within the embryo or fetus to match growth and metabolic phenotype to predicted postnatal nutrient availability. However, such responses may become maladaptive if predicted and actual nutrient levels are inconsistent, leading to adult onset cardiovascular and metabolic diseases (Gluckman & Hanson, 2004; McMillen & Robinson, 2005). Effects on developmental plasticity could also be induced in the periconceptual period, affecting oocyte maturation as well as embryo development, and this is the subject of the current study.

In mammals, oocyte maturation is characterized by the resumption of meiosis, extrusion of the first polar body and reorganization of cytoplasmic constituents for fertilization. Acquisition of oocyte developmental competence does not occur in isolation, but is dependent upon the surrounding somatic cumulus cells with which there is a complex exchange of developmental signals mediated via gap junctions and diverse pathways including Kit, GDF (growth differentiation factor) and BMP (bone morphogenetic protein) components (Eppig, 2001; Amleh & Dean, 2002; Kidder & Mhawi, 2002; Richards et al. 2002; Thomas & Vanderhyden, 2006). Several studies have shown oocyte maturation to be sensitive to environmental conditions which may also have more long-term developmental consequences. In vitro maturation of mouse, sheep and human oocytes reduces their viability and developmental competence (Eppig & Schroeder, 1989; Barnes et al. 1996; Mikkelsen et al. 1999; Bertolini et al. 2002), resulting in altered fetal growth (Bertolini et al. 2002). In vivo, follicular growth and oocyte quality are affected by a range of dietary manipulations in domestic animals (Armstrong et al. 2001). Thus, dietary energy levels influence both follicle morphology and number and the composition of follicular fluid in ewes and heifers (O'Callaghan et al. 2000; Boland et al. 2001), while increased protein and urea intake and associated elevation in ammonia in follicular fluid result in reduced blastocyst development (McEvoy et al. 1997; Sinclair et al. 2000; Adamiak et al. 2005; Powell et al. 2006). However, it is unclear from in vivo studies to date what the relative sensitivity of oocyte or embryo environments might be to periconceptual dietary challenge maintained both before and after mating (Edwards & McMillen, 2002: Sinclair et al. 2007). In contrast, the embryo environment in vivo has been clearly demonstrated to be sensitive to maternal diet restriction (Kwong et al. 2000; Watkins et al. 2008).

Using a mouse model with large sample size, we have investigated the effect of maternal dietary protein restriction during oocyte maturation on postnatal growth, behaviour and cardiovascular physiology. We have found that maternal low protein diet (LPD) provided exclusively during oocyte maturation has minimal effects on postnatal growth but results in abnormal anxiety-related behaviour, elevated systolic blood pressure, reduced vascular responsiveness and altered kidney allometry and organization. Our results indicate firstly that oocyte maturation is a sensitive period with respect to maternal diet and onset of adult disease, and secondly that the oocyte and early embryo exhibit common and distinct environmental susceptibilities that may derive from the presence or absence of the paternal genome.


Animal treatments

These were conducted using protocols approved by the UK Home Office and local ethics committee. Female MF-1 mice were bred in-house (University of Southampton Biomedical Research Facility) and maintained on 07.00–19.00 h light cycle with controlled temperature and standard chow and water ad libitum. Vaginal smears were taken from virgin females (7–8.5 weeks) to determine metoestrus at which point females were singly caged and randomly assigned either the normal protein diet (NPD; 18% casein) or isocaloric low protein diet (LPD; 9% casein; Kwong et al. 2000; Watkins et al. 2008). After 3.5 days, females were mated overnight with MF-1 males (Harlan). Plug-positive females were placed on NPD and individually housed for the remainder of gestation whilst plug-negative females were removed from the study. In total, 19 females of each dietary treatment (NPD and LPD) were allowed to develop their pregnancies to term, at which time all animals were returned to standard chow. Offspring were weighed on the day of birth and weekly for up to 28 weeks. Where possible, litter size was adjusted at birth to six (three males and three females). At 3 weeks, offspring were weaned and the sexes caged separately. Animal coding allowed for all outcome analyses to be conducted ‘blind’ to ensure objectivity.


At 4, 5, 6, 8, 11, 14, 17 and 20 weeks, offspring were subjected to species-specific locomotory, anxiety-related (open field) and affective (burrowing, nesting, glucose solution consumption) activity tests as previously described (Guenther et al. 2001; Cunningham et al. 2003, 2007; Watkins et al. 2008). Weeks 4–6 were taken as acclimatory and weeks 8–20 as assay tests. The illuminated open field (white PVC arena, 30 cm2) test comprised 3 min observations with automated recording of total distance travelled, number of hind rears, jumps, time spent resting and average velocity.

Systolic blood pressure (SBP)

SBP was determined at 9, 15 and 21 weeks by tail-cuff plethysmography as previously described (Watkins et al. 2006). Briefly, mice were allowed to acclimatize to 27–30°C before four recordings were taken per mouse; heart rate was monitored as an indicator of stress (Langley-Evans et al. 1996).

Mesenteric vasoreactivity

Vascular function in male offspring was assessed at 22 weeks in isolated small mesenteric arteries following cervical dislocation. The mesenteric arcade was excised and immersed in physiological salt solution (PSS; Torrens et al. 2003) at 4°C. Small mesenteric arteries (luminal diameter ca 100–300 μm) were dissected free of connective tissue and mounted in PSS on a wire myograph (Multi Myograph Model 610M; JP Trading, Aarhus, Denmark) for analysis of isometric tension as previously described (Brawley et al. 2003; Torrens et al. 2003, 2006). Briefly, following normalization, cumulative concentration–response curves (CRCs) were measured for the α1-adrenergic agonist phenylephrine (PE; 10−9 to 10−4m). Vessels were then preconstricted with a submaximal dose of PE (EC80) and CRCs to the endothelium-dependent vasodilator acetylcholine (ACh; 10−9 to 10−5m), the β-adrenoceptor agonist isoprenaline (ISO; 10−10 to 10−6m) and the endothelium-independent vasodilator sodium nitroprusside (SNP; 10−11 to 10−5m) were conducted in that order. All drugs were purchased from Sigma (Poole, Dorset, UK).

Kidney nephron counting

At 28 weeks, female mice were terminally anaesthetized by an intraperitoneal injection of a ketamine (Fort Dodge) acepromazine (C-Vet) anaesthetic followed by thoracotomy. A butterfly needle (Venisystems, Butterfly −23 ST) was inserted into the left ventricle and the vena cava was cut. Mice were perfused with ~15 ml heparinized saline (0.5 units ml−1 saline, Sigma) at a mean pressure of 100 mmHg to prevent clot formation in the kidney, followed by ~15 ml neutral buffered formalin (Gurr). Left kidneys were removed and immersion-fixed in formalin for 48 h, followed by overnight dehydration through graded alcohols (Leica TP 1020 tissue processor). Each kidney was cut into eight pieces (left/right, anterior/posterior and dorsal/ventral portions) and processed into glycol methacrylate (JB-4 Embedding Kit; Polysciences Europe GmbH, Germany). In preliminary studies, the two blocks comprising anterior, dorsal, left and right kidney pieces were found not to differ significantly in nephron number from the remaining six blocks and were subsequently used as representative of the entire kidney. These blocks were exhaustively sectioned at 2 μm using an ultramicrotome (R. Jung, Heidelberg). Every 100th and 110th section was mounted and stained with toluidine blue (1% toluidine blue w/v in 1% sodium tetraborate w/v in distilled water) for approximately 5–10 s, dried and coverslipped with DPX (Gurr). Unbiased stereological counting was carried out using Stereo Investigator (Microbrightfield, Williston, VT, USA) software connected to a Dialux 22 microscope (Leica) with a motorized x-y-z stage (Ludl, Hawthorne, NY, USA) and a DEI-750D video camera (Optronics, Goleta, CA, USA). An unbiased counting frame (500 μm square) was randomly placed over the 100th section and glomeruli within or touching the inclusion lines were counted. The trace was then overlaid on the 110th section and glomeruli present here but absent from the 100th section were counted. On average, 10–15 pairs of sections were analysed per block and an estimate of kidney glomerular number was obtained using the fractionator principle (Bertram, 1995).

Angiotensin-converting enzyme (ACE) activity

Serum and lung ACE activity were analysed as previously described (Watkins et al. 2006, 2007). Briefly, serum samples were incubated in the presence of hippuryl-l-histidine-l-leucine acetate salt (HHLA; Sigma) solution in phosphate buffer at 37°C followed by addition of cyanuric chloride (Sigma, Poole, Dorset, UK) in 1,4-dioxane (Sigma, Poole, Dorset, UK). Four replicates per sample were analysed on a Dynex MRX2 plate reader at 380 nm. Samples containing only serum and buffer were used as negative controls. Sample readings were analysed against a standard curve prepared in buffer and treated exactly as the samples. Serum ACE activity was expressed as nanomoles of hippurate formed per millilitre of serum per minute; 15–17 samples per treatment group were analysed. The intra- and interassay variation was 3.88% and 17.1%, respectively.

Lung tissue (approximately 50 mg) was homogenized in buffer, centrifuged and the supernatant removed and stored. The pellets were homogenized a second time and the supernatants removed after centrifugation as before. Samples of each extract were mixed with buffer, water and hippuryl-l-histidine-l-leucine acetate salt (Sigma, Poole, Dorset, UK). Negative controls included the addition of HCl prior to addition of the hippuryl-l-histidine-l-leucine. Samples and blanks were incubated at 37°C prior to the addition of HCl, NaOH, KH2PO4 and cyanuric chloride. Sample readings were analysed against a standard curve prepared in buffer and treated exactly as the samples. Samples were analysed in duplicate on a Dynex MRX2 plate reader at 380 nm, and an average activity taken. Tissue protein content was measured using the Bio-Rad protein assay kit. Tissue ACE activity was expressed as nanomoles hippurate formed per milligram of protein per minute. The intra- and interassay variation was 16.9% and 22%, respectively.

Organ allometry

At 28 weeks, following cervical dislocation, blood samples were removed via heart puncture and liver, left and right kidneys, heart, lungs and brain were dissected, weighed, and snap frozen in liquid nitrogen and stored at −80°C.

Statistical analyses

Student's t test was used to analyse mean gestational litter size and male : female ratio (SigmaStat statistical software, version 3.5). Vascular responsiveness data (cumulative concentration–response curves) were analysed using 2-way ANOVA (Prism 3.0, GraphPad Software Inc.) as previously (Torrens et al. 2003, 2006). All other postnatal data (birth weight, postnatal weights, behavioural data, SBP, organ weights and ratios, kidney glomerular number and correlations) were analysed using a multilevel random effects regression model (SPSS version 14) which takes into account the hierarchical nature of the data with between-mother and within-mother variation and different parameters measured from individual animals (Kwong et al. 2004; Watkins et al. 2006). Thus, differences identified between treatment groups throughout the study are independent of maternal origin of litter, gestational litter size and body weight, unless otherwise stated. Week of testing was included in the analysis of the behavioural data.


Litter size, birth weight and postnatal growth

Gestation length, gestational litter size and offspring sex ratio were not significantly different between dietary groups (Table 1). LPD males displayed a trend towards elevated mean birth weight when compared to NPD males (Fig. 1; P = 0.073) independent of gestational litter size and sex ratio. No difference in birth weight was observed between female groups. No difference in mean weekly weight was evident between treatment groups up to 28 weeks (Fig. 2A and B).

Table 1
Litter size and birth criteria (±s.e.m.) of offspring from low protein diet (LPD) and normal protein diet (NPD) treatment groups
Figure 1
Maternal low protein diet (LPD) during oocyte maturation causes an elevation in birth weight in male offspring at a trend level (P = 0.073) independent of maternal origin and gestational litter size
Figure 2
Maternal LPD during oocyte maturation has no effect on postnatal growth


When examined on an individual week basis, LPD males displayed reduced distance travelled at 14, 17 and 20 weeks (reduced by 37.4, 54 and 40.5%, respectively, versus NPD; all P < 0.03), and increased time resting at 17 weeks (by 9.1%versus NPD; P = 0.039) compared to NPD males. LPD females also displayed reduced distance travelled at 20 weeks (by 38.4%; P = 0.037), reduced numbers of rears at 8, 11, 14 and 20 weeks (by 36.7, 35.94, 41.4 and 49.8%versus NPD: P < 0.035), reduced numbers of jumps at 8, 14 and 20 weeks (by 48.3, 69.74, 89.3%versus NPD; P < 0.05), increased time resting at 14, 17 and 20 weeks (by 5.0, 2.8, 8.4%versus NPD; P≤ 0.05) and increased velocity at 11 weeks (by 41.2%; P = 0.042). All differences were independent of maternal origin and gestational litter size. Integration of all weekly data into mean open field activities, taking into account week of testing, showed that the male LPD offspring displayed reduced mean distance travelled, number of rears and jumps, increased velocity (P < 0.005), and a trend towards an increased time spent resting (Fig. 3A; P = 0.071). LPD females also displayed reduced distance travelled, mean number of rears and jumps, increased time resting and increased velocity compared to NPD females (Fig. 3B; P < 0.01). Analysis of affective behaviour showed LPD females displaying a trend towards increased burrowing activity after 2 h and overnight (by 16.5 and 5.7%, respectively, versus NPD; P = 0.096 and 0.087); however, no differences were observed between treatment groups for either glucose solution consumption or nest construction (data not shown).

Figure 3
Maternal LPD during oocyte maturation leads to changes in postnatal behaviour

Systolic blood pressure

Mean systolic blood pressure (SBP) of offspring was determined at 9, 15 and 21 weeks, with the mean of these values recorded as ‘Life SBP’ (Fig. 4A and B). LPD males displayed elevated SBP at all assay times (4.23% higher Life SBP than NPD; P = 0.002; Fig. 4A) whilst LPD females had a trend towards a higher SBP at 15 weeks (P = 0.09) and significantly higher SBP at 21 weeks and for Life SBP (2.88% higher Life SBP than NPD; P = 0.01; Fig. 4B). Whilst these data were independent of maternal origin and body weight, gestational litter size positively influenced 21 week SBP in males (+1.11 mmHg per value increase in litter size, P = 0.034), and Life SBP in females (+0.68 mmHg per value increase in litter size, P = 0.014).

Figure 4
Maternal LPD during oocyte maturation induces an elevation in postnatal SBP

Mesenteric artery vasoreactivity

The α1-adrenergic agonist PE produced a concentration-dependent vasoconstriction which was similar in LPD and NPD males (Fig. 5A). Vasodilatation to the endothelium-dependent vasodilator ACh and the β-adrenoceptor agonist ISO in PE-preconstricted arteries was attenuated in the LPD group (Fig. 5B and C; P = 0.001 and 0.014, respectively). Dilatation to the endothelium-independent vasodilator SNP was similar between the two groups (Fig. 5D).

Figure 5
Maternal LPD during oocyte maturation reduces the vasoreactivity of isolated male offspring mesenteric arteries at 22 weeks

Organ allometry

No differences in organ weights (liver, kidney, heart, lung, brain and cerebellum) or organ : body weight ratios were evident between LPD and NPD males at 28 weeks (Table 2A). However, LPD females had reduced right (Table 2B, P = 0.031) and combined (data not shown; P = 0.044) kidney : body weight ratios compared to NPD females. A positive correlation was present between both left and right kidney : body weight ratios and Life SBP in LPD males (Fig. 6A and B; P < 0.007), different (P < 0.015) to NPD males which showed no correlation between these factors. LPD males also displayed a positive correlation between heart : body weight ratio and Life SBP (Fig. 6C; P = 0.004), different from NPD males (P = 0.05) which showed no correlation between these factors. All differences were independent of maternal origin and gestational litter size.

Table 2
Mean organ weight (g) and organ : body weight ratio of male (A; n = 27–42 per treatment) and female (B; n = 30–39 per treatment) offspring
Figure 6
Maternal LPD during oocyte maturation alters the correlation between organ : body weight ratios and Life SBP in offspring

Kidney nephron counts

Morphometric analysis of left kidney glomerular number in female offspring at 28 weeks revealed increased numbers within the LPD group (28.1% higher than NPD; P = 0.03; Fig. 7A). When mean glomerular number was expressed as per gram or cubic centimetre of kidney tissue, LPD kidneys demonstrated a significant increase and a trend towards an increased glomerular number, respectively (32.8 and 35.1% higher than NPD; P = 0.031 and 0.091, respectively; Fig. 7A). Whilst these data were independent of gestational litter size and kidney weight effects, when mean glomerular number per cubic centimetre was analysed independently of litter size, a significant increase was observed for the LPD group (P = 0.036). Analysis of glomerular number : Life SBP correlation revealed the LPD group to have a negative correlation (r2=–0.902, P = 0.007), whilst the NPD group displayed no correlation (r2= 0.382, P = 0.228; Fig. 7B).

Figure 7
Maternal LPD during oocyte maturation increases kidney mean glomerular number (GN) in female LPD offspring at 28 weeks

Angiotensin-converting enzyme (ACE) activity

No difference in serum ACE activity was observed between NPD and LPD males (126.22 ± 14.30 and 146.53 ± 14.19 nmol hippurate, respectively, P > 0.05), or females (81.14 ± 8.00 and 105.17 ± 12.53 nmol hippurate, respectively, P > 0.05, data not shown). No difference in lung ACE activity was observed between NPD and LPD males (3.25 ± 0.52 and 3.11 ± 0.48 nmol hippurate, respectively, P > 0.05) or females (3.30 ± 0.38 and 3.45 ± 0.67 nmol hippurate, respectively, P > 0.05, data not shown).


Collectively, our data demonstrate that maternal LPD treatment exclusively during mouse oocyte maturation (3.5 days prior to conception) is sufficient to alter postnatal phenotype resulting in behavioural and cardiovascular changes indicative of adult disease. These findings, together with those previously identified by maternal protein restriction exclusively during preimplantation development (Kwong et al. 2000; Watkins et al. 2008), or during both pre- and post-fertilization periods (Edwards & McMillen, 2002: Sinclair et al. 2007), provide strong support for the DOHaD hypothesis and the vulnerability of the periconceptual period, including that of oocyte maturation, to environmental conditions.

Analysis of postnatal behavioural outcomes revealed predominant effects induced by LPD treatment during oocyte maturation, on both male and female offspring. These included altered open field activity, notably reduced exploratory behaviour (distance travelled, rearing, jumping), increased time spent resting, and increased velocity. Behavioural testing for species-typical spontaneous activities as used here provide sensitive assays of well-being, devised to identify a mild sickness phenotype in murine prion and related disease models prior to the detection of clinical biochemical symptoms (Guenther et al. 2001; Cunningham et al. 2003, 2007). The reduced exploratory activity and longer rest periods are difficult to interpret in isolation but these deficits signify reduced responsiveness to environmental stimuli which may associate with increased anxiety and/or a change in affective behaviour (Guenther et al. 2001; Cunningham et al. 2003, 2007). Altered postnatal open field activity has also been identified, especially in females, in response to maternal LPD restricted to the preimplantation period, further indicating the importance of periconceptual dietary environment on adult behaviour (Watkins et al. 2008).

The second major change in phenotype detected in offspring following maternal LPD treatment during oocyte maturation is associated with the cardiovascular system. Male and female LPD offspring developed relative hypertension with females showing delay in its inception but, in both sexes, Life SBP was elevated significantly. We believe this is the first report to demonstrate hypertension associated with maternal protein restriction during the period of oocyte maturation alone, although LPD treatment during pregnancy or limited to the preimplantation period has been shown previously to lead to raised SBP in rodent models (Langley & Jackson, 1994; Kwong et al. 2000; Fleming et al. 2004; Gluckman & Hanson, 2004; McMillen & Robinson, 2005; Sinclair & Singh, 2007; Watkins et al. 2008). The origins of hypertension using these models for gestational diet restriction, together with domestic animal models, appear complex and may involve alteration to the hypothalamic–pituitary–adrenal (HPA) axis and the renin–angiotensin system during fetal development leading to loss of normal cardiovascular control and peripheral vessel dysfunction (Brawley et al. 2003; Torrens et al. 2003, 2006; Fleming et al. 2004; Gluckman & Hanson, 2004; McMillen & Robinson, 2005).

To interpret the potential contributory components of hypertension in LPD offspring, we examined arterial vessel responsiveness to both vasoconstrictors and endothelium-dependent and -independent vasodilators in male offspring. We found that mesenteric arteries from LPD animals displayed attenuated dilatation to ACh and ISO. Such effects have been shown to associate with aspects of cardiovascular disease in the rat following maternal LPD during pregnancy (Brawley et al. 2003; Torrens et al. 2003, 2006). These data indicate that reduced vascular responsiveness in males may be mediated through endothelial-dependent mechanisms, possibly associated with nitric oxide and/or β-adrenoceptor pathways (Brawley et al. 2003; Torrens et al. 2003, 2006).

Our other studies to evaluate cardiovascular phenotype have focused on the female kidney, which has been shown to be reduced in size with reduced nephron number as a result of gestational maternal diet restriction in several species (Zandi-Nejad et al. 2006; Bagby, 2007), including the mouse (Hoppe et al. 2007). Compromised kidney development during late gestation may reflect a fetal ‘strategy’ to protect vital organ development such as the brain and heart at the expense of abdominal organs in response to restricted nutrient availability (McMillen & Robinson, 2005; Bagby, 2007). Whilst reduced kidney growth or body weight in offspring coincides with reduced nephron number and hypertension in several (Langley-Evans et al. 1999; Bagby, 2007) but not all (Woods et al. 2005) models of gestational diet restriction, our findings are unusual in that maternal LPD female offspring exhibited reduced kidney size coupled with increased nephron number. These changes in kidney size also altered the relationship with Life SBP. Given that kidney development occurs late in gestation and that our dietary challenge actually precedes the initiation of the developmental programme, it is possible that the kidney phenotype of increased nephron number may reflect a compensatory response to the maternal challenge. Indeed, the negative correlation observed between Life SBP and kidney nephron number identified in the female LPD group supports this contention. However, further molecular and biochemical studies on kidney morphogenesis and postnatal function in response to protein restriction during oocyte maturation are required to interpret more fully the kidney phenotype and its relationship with cardiovascular health.

The diverse outcomes identified in offspring following maternal LPD during oocyte maturation indicate that nutrition prior to conception is critical in the setting of homeostatic regulators affecting health and disease risk. Whilst the discrete nature of the dietary challenge allows us to focus on the health implications for a specific period of the reproductive cycle, and also to make comparisons between different periods (discussed below), we need to consider two alternative interpretations of our outcomes. First, the outcomes may also reflect a persistence of the dietary challenge on maternal environment and physiology beyond that of oocyte maturation into early development. Second, the outcomes may also reflect changes in maternal environment induced by the stress of the diet change itself. We cannot exclude either of these factors contributing to outcomes but, nevertheless, it would be reasonable to conclude that even if they were, then a changed diet during oocyte maturation would still be the upstream mediator, a factor pertinent in any extrapolation to the human situation and the importance of dietary practice prior to conception. However, we feel that these two indirect components are likely to be minimal for the following reasons. First, in our previous mouse diet analysis focusing on the preimplantation period (Watkins et al. 2008), the outcomes identified compared to here were distinct but with some shared responses (discussed below) suggesting that the discrete nature of the challenges were having specific effects at that time rather than persisting longer. Second, in that study, embryo transfer was conducted of LPD embryos into NPD recipients to test directly whether a persistent effect on the maternal environment was contributory to outcomes. This revealed that the LPD-induced effect on the embryo was preserved in the absence of a maternal LPD environment after transfer, confirming the derivation of the outcome to maternal diet during preimplantation development. Whilst a similar strategy of analysing embryo transfers in the current study would notionally confirm the origin of our findings, and will be considered for future studies, the transfer procedure and in vitro treatment involved may generate confounding stress-related responses as these would need to be conducted on the stage immediately following oocyte maturation, the period of fertilization-mediated signalling of embryonic genome activation known for its environmental sensitivity (Gardner & Lane, 1996; Qiu et al. 2003). Indeed, in an earlier study where we investigated the effects of embryo culture on postnatal outcomes, blastocyst transfer itself was found to affect outcomes but minimally compared to the embryo culture challenge (Watkins et al. 2007).

Comparison of the postnatal phenotypes induced in mice in response to maternal LPD experienced during oocyte maturation here with that during preimplantation embryo development (Watkins et al. 2008) gives further insight into potential mechanisms. Whilst hypertension in male and female offspring and behavioural changes, predominantly in female offspring, are evident in both models, the major distinction is in the effect on fetal and postnatal growth, only evident in response to maternal LPD during preimplantation development (Watkins et al. 2008). Whilst, in the current study, we are challenging a different phase in the reproductive cycle (gamete versus preimplantation embryo development), and therefore cannot discount the effect this may have upon postnatal development, one important distinction between the two models is the presence of the paternal genome at the time of dietary challenge during the preimplantation period. A critical role has been identified for genomic imprinting in controlling growth of the conceptus during pregnancy by, for example, modulating placental efficiency for maternal–fetal nutrient delivery and coordinating growth factor ligand–receptor interactions (Angiolini et al. 2006; Smith et al. 2006). Thus, paternal and maternal alleles of imprinted genes may confer opposing effects in such mechanisms, reflecting the need for the paternal genome to promote fetal growth and the maternal genome to temper this to protect maternal health for later pregnancies. The ‘conflict hypothesis’ embodies these divergent genomic strategies (Angiolini et al. 2006; Smith et al. 2006). Changes in the expression (but to date not changes in DNA methylation status) of imprinted genes have been identified in preimplantation embryos and their derivative tissues in response to maternal LPD (Kwong et al. 2006). Moreover, changes in expression and/or DNA methylation status of imprinted genes have been shown following embryo in vitro culture treatments (Doherty et al. 2000; Khosla et al. 2001; Young et al. 2001; Mann et al. 2004). Thus, the distinct effects on growth control mediated by maternal LPD during oocyte maturation versus preimplantation development may reflect differential effects on the paternal genome.

In conclusion, we show that oocyte maturation in mice is sensitive in vivo to maternal dietary protein level with behavioural and cardiovascular markers of postnatal health being adversely affected in conditions of protein undernutrition. These novel findings support the contention that periconceptual environment including both before and after fertilization, and both in vitro and in vivo, associates with adult health and disease risk. Whilst our data here using an animal model cannot be extrapolated directly to the human, we consider animal models as useful in identifying potential relationships that merit separate investigation across species including the human. Given that preimplantation programming of adult disease has been shown to comprise a complex of mechanisms acting at epigenetic, physiological and cellular levels (Fernandez-Gonzalez et al. 2004), further studies are required to elucidate how oocyte maturation may be affected by maternal diet with such long-lasting consequences.


This work was supported by the National Institutes of Health, USA as part of the NICHD National Cooperative Program on Female Health and Egg Quality under cooperative agreement U01 HD044635, and the Gerald Kerkut Charitable Trust. M.A.H. is supported by the British Heart Foundation. We thank Rebecca Brennan for assistance in kidney nephron counting and the Biomedical Facility, University of Southampton, for their technical support.


  • Adamiak SJ, Mackie K, Watt RG, Webb R, Sinclair KD. Impact of nutrition on oocyte quality: cumulative effects of body composition and diet leading to hyperinsulinemia in cattle. Biol Reprod. 2005;73:918–926. [PubMed]
  • Amleh A, Dean J. Mouse genetics provides insight into folliculogenesis, fertilization and early embryonic development. Hum Reprod Update. 2002;8:395–403. [PubMed]
  • Angiolini E, Fowden A, Coan P, Sandovici I, Smith P, Dean W, Burton G, Tycko B, Reik W, Sibley C, Constancia M. Regulation of placental efficiency for nutrient transport by imprinted genes. Placenta. 2006;27(Suppl. A):S98–S102. [PubMed]
  • Armstrong DG, McEvoy TG, Baxter G, Robinson JJ, Hogg CO, Woad KJ, Webb R, Sinclair KD. Effect of dietary energy and protein on bovine follicular dynamics and embryo production in vitro: associations with the ovarian insulin-like growth factor system. Biol Reprod. 2001;64:1624–1632. [PubMed]
  • Bagby SP. Maternal nutrition, low nephron number, and hypertension in later life: pathways of nutritional programming. J Nutr. 2007;137:1066–1072. [PubMed]
  • Barnes FL, Kausche A, Tiglias J, Wood C, Wilton L, Trounson A. Production of embryos from in vitro-matured primary human oocytes. Fertil Steril. 1996;65:1151–1156. [PubMed]
  • Bertolini M, Mason JB, Beam SW, Carneiro GF, Sween ML, Kominek DJ, Moyer AL, Famula TR, Sainz RD, Anderson GB. Morphology and morphometry of in vivo- and in vitro-produced bovine concepti from early pregnancy to term and association with high birth weights. Theriogenology. 2002;58:973–994. [PubMed]
  • Bertram JF. Analyzing renal glomeruli with the new stereology. Int Rev Cytol. 1995;161:111–172. [PubMed]
  • Boland MP, Lonergan P, O'Callaghan D. Effect of nutrition on endocrine parameters, ovarian physiology, and oocyte and embryo development. Theriogenology. 2001;55:1323–1340. [PubMed]
  • Brawley L, Itoh S, Torrens C, Barker A, Bertram C, Poston L, Hanson M. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res. 2003;54:83–90. [PubMed]
  • Cunningham C, Campion S, Teeling J, Felton L, Perry VH. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) Brain Behav Immun. 2007;21:490–502. [PubMed]
  • Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, Scott H, Rawlins JN, Perry VH. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci. 2003;17:2147–2155. [PubMed]
  • Doherty AS, Mann MR, Tremblay KD, Bartolomei MS, Schultz RM. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod. 2000;62:1526–1535. [PubMed]
  • Ecker DJ, Stein P, Xu Z, Williams CJ, Kopf GS, Bilker WB, Abel T, Schultz RM. Long-term effects of culture of preimplantation mouse embryos on behavior. Proc Natl Acad Sci U S A. 2004;101:1595–1600. [PMC free article] [PubMed]
  • Edwards LJ, McMillen IC. Periconceptional nutrition programs development of the cardiovascular system in the fetal sheep. Am J Physiol Regul Integr Comp Physiol. 2002;283:R669–R679. [PubMed]
  • Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction. 2001;122:829–838. [PubMed]
  • Eppig JJ, Schroeder AC. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro. Biol Reprod. 1989;41:268–276. [PubMed]
  • Fernandez-Gonzalez R, Moreira P, Bilbao A, Jimenez A, Perez-Crespo M, Ramirez MA, Rodriguez DF, Pintado B, Gutierrez-Adan A. Long-term effect of in vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, development, and behavior. Proc Natl Acad Sci U S A. 2004;101:5880–5885. [PMC free article] [PubMed]
  • Fleming TP, Kwong WY, Porter R, Ursell E, Fesenko I, Wilkins A, Miller DJ, Watkins AJ, Eckert JJ. The embryo and its future. Biol Reprod. 2004;71:1046–1054. [PubMed]
  • Gardner DK, Lane M. Alleviation of the ‘2-cell block’ and development to the blastocyst of CF1 mouse embryos: role of amino acids, EDTA and physical parameters. Hum Reprod. 1996;11:2703–2712. [PubMed]
  • Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305:1733–1736. [PubMed]
  • Guenther K, Deacon RM, Perry VH, Rawlins JN. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci. 2001;14:401–409. [PubMed]
  • Hoppe CC, Evans RG, Bertram JF, Moritz KM. Effects of dietary protein restriction on nephron number in the mouse. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1768–R1774. [PubMed]
  • Khosla S, Dean W, Reik W, Feil R. Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Hum Reprod Update. 2001;7:419–427. [PubMed]
  • Kidder GM, Mhawi AA. Gap junctions and ovarian folliculogenesis. Reproduction. 2002;123:613–620. [PubMed]
  • Kwong WY, Miller DJ, Ursell E, Wild AE, Wilkins AP, Osmond C, Anthony FW, Fleming TP. Imprinted gene expression in the rat embryo-fetal axis is altered in response to periconceptional maternal low protein diet. Reproduction. 2006;132:265–277. [PubMed]
  • Kwong WY, Osmond C, Fleming TP. Support for Barker hypothesis upheld in rat model of maternal undernutrition during the preimplantation period: application of integrated ‘random effects’ statistical model. Reprod Biomed Online. 2004;8:574–576. [PubMed]
  • Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development. 2000;127:4195–4202. [PubMed]
  • Langley SC, Jackson AA. Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci (Lond) 1994;86:217–222. [PubMed]
  • Langley-Evans SC, Gardner DS, Jackson AA. Association of disproportionate growth of fetal rats in late gestation with raised systolic blood pressure in later life. J Reprod Fertil. 1996;106:307–312. [PubMed]
  • Langley-Evans SC, Welham SJ, Jackson AA. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci. 1999;64:965–974. [PubMed]
  • McEvoy TG, Robinson JJ, Aitken RP, Findlay PA, Robertson IS. Dietary excesses of urea influence the viability and metabolism of preimplantation sheep embryos and may affect fetal growth among survivors. Anim Reprod Sci. 1997;47:71–90. [PubMed]
  • McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85:571–633. [PubMed]
  • Mann MR, Lee SS, Doherty AS, Verona RI, Nolen LD, Schultz RM, Bartolomei MS. Selective loss of imprinting in the placenta following preimplantation development in culture. Development. 2004;131:3727–3735. [PubMed]
  • Mikkelsen AL, Smith SD, Lindenberg S. In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod. 1999;14:1847–1851. [PubMed]
  • O'Callaghan D, Yaakub H, Hyttel P, Spicer LJ, Boland MP. Effect of nutrition and superovulation on oocyte morphology, follicular fluid composition and systemic hormone concentrations in ewes. J Reprod Fertil. 2000;118:303–313. [PubMed]
  • Powell K, Rooke JA, McEvoy TG, Ashworth CJ, Robinson JJ, Wilmut I, Young LE, Sinclair KD. Zygote donor nitrogen metabolism and in vitro embryo culture perturbs in utero development and IGF2R expression in ovine fetal tissues. Theriogenology. 2006;66:1901–1912. [PubMed]
  • Qiu JJ, Zhang WW, Wu ZL, Wang YH, Qian M, Li YP. Delay of ZGA initiation occurred in 2-cell blocked mouse embryos. Cell Res. 2003;13:179–185. [PubMed]
  • Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol. 2002;64:69–92. [PubMed]
  • Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, Thurston A, Huntley JF, Rees WD, Maloney CA, Lea RG, Craigon J, McEvoy TG, Young LE. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A. 2007;104:19351–19356. [PMC free article] [PubMed]
  • Sinclair KD, Kuran M, Gebbie FE, Webb R, McEvoy TG. Nitrogen metabolism and fertility in cattle. II. Development of oocytes recovered from heifers offered diets differing in their rate of nitrogen release in the rumen. J Anim Sci. 2000;78:2670–2680. [PubMed]
  • Sinclair KD, McEvoy TG, Maxfield EK, Maltin CA, Young LE, Wilmut I, Broadbent PJ, Robinson JJ. Aberrant fetal growth and development after in vitro culture of sheep zygotes. J Reprod Fertil. 1999;116:177–186. [PubMed]
  • Sinclair KD, Singh R. Modelling the developmental origins of health and disease in the early embryo. Theriogenology. 2007;67:43–53. [PubMed]
  • Smith FM, Garfield AS, Ward A. Regulation of growth and metabolism by imprinted genes. Cytogenet Genome Res. 2006;113:279–291. [PubMed]
  • Thomas FH, Vanderhyden BC. Oocyte–granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol. 2006;4:19. [PMC free article] [PubMed]
  • Thompson JG, Gardner DK, Pugh PA, McMillan WH, Tervit HR. Lamb birth weight is affected by culture system utilized during in vitro pre-elongation development of ovine embryos. Biol Reprod. 1995;53:1385–1391. [PubMed]
  • Torrens C, Brawley L, Anthony FW, Dance CS, Dunn R, Jackson AA, Poston L, Hanson MA. Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension. 2006;47:982–987. [PubMed]
  • Torrens C, Brawley L, Barker AC, Itoh S, Poston L, Hanson MA. Maternal protein restriction in the rat impairs resistance artery but not conduit artery function in pregnant offspring. J Physiol. 2003;547:77–84. [PMC free article] [PubMed]
  • Watkins AJ, Platt D, Papenbrock T, Wilkins A, Eckert JJ, Kwong WY, Osmond C, Hanson M, Fleming TP. Mouse embryo culture induces changes in postnatal phenotype including raised systolic blood pressure. Proc Natl Acad Sci U S A. 2007;104:5449–5454. [PMC free article] [PubMed]
  • Watkins AJ, Ursell E, Panton R, Papenbrock T, Hollis L, Cunningham C, Wilkins A, Perry VH, Sheth B, Kwong WY, Eckert JJ, Wild AE, Hanson MA, Osmond C, Fleming TP. Adaptive responses by mouse early embryos to maternal diet protect fetal growth but predispose to adult onset disease. Biol Reprod. 2008;78:299–306. [PubMed]
  • Watkins A, Wilkins A, Osmond C, Warner CM, Comiskey M, Hanson M, Fleming TP. The influence of mouse Ped gene expression on postnatal development. J Physiol. 2006;571:211–220. [PMC free article] [PubMed]
  • Woods LL, Ingelfinger JR, Rasch R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1131–R1136. [PubMed]
  • Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet. 2001;27:153–154. [PubMed]
  • Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension. 2006;47:502–508. [PubMed]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...